Article Details

Eidos Therapeutics, Inc. (EIDX) Reaches $63.50 52-Week High; Crosslink Capital Has Upped ...

Retrieved on: 2019-12-14 04:34:23

Tags for this article:

Click the tags to see associated articles and topics

Eidos Therapeutics, Inc. (EIDX) Reaches $63.50 52-Week High; Crosslink Capital Has Upped .... View article details on hiswai:

Excerpt

<div><b>Crosslink Capital</b> Inc increased Salesforce.Com (CRM) stake by 1414.77% reported in 2019Q3 SEC filing. <b>Crosslink Capital</b> Inc acquired 199,964 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up